비교리스트

 카트 문의
시장보고서
상품코드
1486840

세계의 주입 치료 기기 시장 : 시장 인사이트, 경쟁 환경, 시장 예측(2030년)

Infusion Therapy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 수액 치료 기기 시장 규모는 2030년까지 776억 5,000만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 6.56%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 수액 치료 장비에 대한 수요 급증은 주로 당뇨병 및 암과 같은 만성 질환의 유병률 증가에 의해 촉진되고 있습니다. 수액 치료 장비는 광범위한 임상 치료를 포괄하고 있으며, 제품 출시가 눈에 띄게 증가하면서 시장이 크게 성장하고 있습니다. 이러한 요인들이 종합적으로 2024-2030년의 예측 기간 동안 수액 치료 기기 시장의 성장 궤도를 개선하는 데 기여할 것입니다.

수액 치료 기기 시장 역학

전 세계적으로 당뇨병과 암이 유행하면서 수액 치료 기기 시장이 크게 성장하고 있습니다. 국제당뇨병연맹(IDF)에 따르면, 2021년 20-79세 성인 5억 3,700만 명이 당뇨병을 앓고 있는 것으로 추정됩니다. 이 숫자는 2030년까지 6억 4,300만 명, 2045년까지 7억 8,300만 명으로 증가할 것으로 예측됩니다. 또한, 5억 4,100만 명이 2형 당뇨병 발병 위험이 높은 내당능장애(IGT)를 앓고 있는 것으로 보고되고 있습니다. 특히 성인 당뇨병 환자의 4분의 3이 중저소득 국가에 거주하고 있어 인슐린 펌프와 같은 첨단 의료기기에 대한 수요가 매우 높다는 점을 주목할 필요가 있습니다. 이러한 의료기기는 인슐린을 지속적이고 정확하게 투여하는 데 필수적이며, 효과적인 혈당 관리에 필수적입니다.

수액 치료 장비에 대한 수요는 미국 암 협회가 발표한 암 통계에 의해서도 촉진되고 있는데, 2020년에는 비흑색종 피부암 1,810만 건을 제외하고 전 세계적으로 1,930만 건의 새로운 암 환자가 발생할 것으로 추정됩니다. 유방암은 신규 환자의 11.7%를 차지하며, 폐암의 11.4%를 넘어 가장 많이 진단되는 암이 될 것으로 예상됩니다. 다른 암으로는 대장암(10.0%), 전립선암(7.3%), 위암(5.6%)이 많습니다. 주입 치료는 화학요법 시행에 필수적이며, 이는 암 치료에서 이러한 장비의 중요한 역할을 더욱 강력하게 보여줍니다.

수액 치료 기기 시장은 또한 업계 기업간의 제휴 및 파트너십 증가로 인해 혜택을 받고 있습니다. 예를 들어, 2023년 8월 핀란드의 의료 기술 기업 Monidor Oy는 국제적인 주요 의료기기 제조업체인 B. Braun과 제휴하여 원격 수액 요법 모니터링을 강화했습니다. 이러한 파트너십은 수액 치료 분야의 발전에 있어 매우 중요한 의미를 지닙니다.

또 다른 중요한 발전으로, 에이탄 메디컬은 2021년 4월에 혁신적인 커넥티드 멀티테라피 외래 수액 시스템인 Avoset을 출시했으며, Avoset은 컴팩트한 디자인과 원격 모니터링 기능을 통해 급성기 이후 치료와 특수 수액 요법을 혁신하고 환자의 안전과 사용자 경험을 향상시킬 수 있도록 설계되었습니다. 환자의 안전과 사용자 경험을 향상시킬 수 있도록 설계되었습니다.

이러한 긍정적인 추세에도 불구하고, 시장은 수액 치료 장비의 높은 비용과 사용에 따른 감염 위험과 같은 문제에 직면해 있습니다. 이러한 요인들은 2024-2030년의 예측 기간 동안 시장 성장을 저해할 수 있습니다. 그러나 당뇨병 및 암과 같은 만성 질환을 효과적으로 관리하려는 수요가 증가함에 따라 수액 치료 기기 시장의 전반적인 성장은 계속될 것으로 예상됩니다.

주입 치료 기기 시장 부문별 분석

주사기 주입 펌프 부문은 2023년 수액 치료 기기 시장에서 큰 매출 점유율을 차지할 것으로 예상됩니다. 주사기 주입 펌프(주사기 드라이버)는 정확도가 높은 것으로 알려진 주사기 주입 펌프(주사기 드라이버)는 약물이나 영양제 등 소량의 수액을 환자의 혈류에 직접 주입하는 데 매우 중요합니다.

시린지 주입 펌프는 여러 가지 장점을 가지고 있어 임상 현장에서 필수적인 장비가 되었습니다. 이 장비는 다재다능하며, 휴대용 및 고정식 사용 모두를 위해 설계되었으며, 온도 제어를 위한 내부 히터가 내장되어 있습니다. 이 기능은 유효성을 유지하기 위해 특정 온도 설정이 필요한 수액 투여에 특히 유용합니다. 또한, 주사기 펌프는 컴퓨터와 상호 작용할 수 있어 의료 제공업체가 기기를 프로그래밍하여 정확도를 높이고 수액 이력을 추적하여 오류 가능성을 최소화 할 수 있습니다.

이 보고서는 세계 주입 치료 기기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 전해드립니다.

목차

제1장 주입 치료 기기 시장 보고서 서론

제2장 주입 치료 기기 시장 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 주입 치료 기기 시장의 주요 요인 분석

  • 주입 치료 기기 시장 성장 촉진요인
  • 주입 치료 기기 시장 성장 억제요인과 과제
  • 주입 치료 기기 시장 기회

제6장 주입 치료 기기 시장 : Porter의 Five Forces 분석

제7장 주입 치료 기기 시장 평가

  • 제품 유형별
    • 시린지 주입 펌프
    • 대용량 펌프(LVP)
    • 엘라스토머 펌프
    • 기타
  • 가동성별
    • 휴대식 주입 펌프
    • 고정식 주입 펌프
  • 용도별
    • 다발성 경화증
    • 당뇨병
    • 류마티스 관절염
    • 암
  • 최종사용자
    • 병원 및 진료소
    • 외래수술센터(ASC)
    • 홈케어
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 주입 치료 기기 시장 기업과 제품 개요

  • Fresenius Kabi AG
  • Ossila
  • Ace-medical
  • ICU Medical
  • Chmyx inc.
  • Mindray
  • Baxter
  • Becton, Dickinson and Company
  • Micrel Medical Devices SA
  • AKAS Infusions
  • Narang Medical Limited
  • Monidor Oy.
  • Smiths Group plc.
  • B. Braun SE
  • Trivitron Healthcare
  • Eitan Medical

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항 및 문의

LSH 24.06.10

Infusion Therapy Devices Market By Product Type (Syringe Infusion Pumps, Large Volume Pumps, Elastomeric Pumps, And Others), Mobility (Portable Infusion Pumps, And Stationary Infusion Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, And Others), End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to rise in the prevalence of chronic disorders and increasing clinical applications of infusion therapy devices

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030. The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy devices market throughout the forecast period spanning from 2024 to 2030.

Infusion Therapy Devices Market Dynamics:

The global prevalence of diabetes and cancer is driving significant growth in the market for infusion therapy devices. According to the International Diabetes Federation (IDF), in 2021, an estimated 537 million adults aged 20-79 were living with diabetes. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Additionally, 541 million individuals were reported to have Impaired Glucose Tolerance (IGT), putting them at high risk of developing Type 2 diabetes. Notably, three-quarters of adults with diabetes reside in low- and middle-income countries, where the need for advanced medical devices like insulin pumps is crucial. These devices are essential for continuous and precise insulin delivery, and vital for effective blood sugar management.

The demand for infusion therapy devices is also bolstered by the cancer statistics published by the American Cancer Society. In 2020, there were an estimated 19.3 million new cancer cases worldwide, excluding 18.1 million cases of non-melanoma skin cancer. Breast cancer has emerged as the most commonly diagnosed cancer, comprising 11.7% of new cases, surpassing lung cancer, which accounts for 11.4% of cases. The other prevalent cancers include colorectal (10.0%), prostate (7.3%), and stomach (5.6%). Infusion therapy is integral to chemotherapy delivery, further underscoring the critical role of these devices in cancer treatment.

The infusion therapy devices market is also benefiting from increased collaborations and partnerships among industry players. For instance, in August 2023, Monidor Oy, a Finnish health technology company, partnered with B. Braun, a leading international medical device manufacturer, to enhance remote IV therapy monitoring. Such partnerships are pivotal in advancing the field of infusion therapy.

In another significant development, Eitan Medical introduced a groundbreaking connected multi-therapy ambulatory infusion system, Avoset, in April 2021. Avoset is designed to transform post-acute care and specialized infusion therapy with its compact design and remote monitoring capabilities, enhancing patient safety and user experience.

Despite these positive trends, the market faces challenges such as the high cost of infusion therapy devices and the risk of infection associated with their use. These factors may restrain market growth during the forecast period of 2024 to 2030. However, the overall expansion of the infusion therapy device market is expected to continue, propelled by the rising need to manage chronic diseases like diabetes and cancer effectively.

Infusion Therapy Devices Market Segment Analysis:

Infusion Therapy Devices Market by Product Type (Syringe Pumps, Large Volume Pumps (LVP), Elastomeric Pumps, and Others), Mobility (Portable Infusion Pumps, and Stationary Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The syringe infusion pump segment is poised to capture a substantial revenue share of the infusion therapy devices market in 2023. Known for their precision, syringe infusion pumps, or syringe drivers, are crucial for administering small volumes of fluids, such as medications or nutrients, directly into a patient's bloodstream.

Syringe infusion pumps offer several advantages, making them indispensable in clinical settings. These devices are versatile, designed for both portable and stationary use, and incorporate an internal heater for temperature control. This feature is particularly beneficial for administering fluids that require specific temperature settings to maintain efficacy. Furthermore, syringe pumps can interface with computers, allowing healthcare providers to program the device for enhanced accuracy and to track the history of infusions, minimizing the potential for errors.

The capability to deliver fluids with higher viscosity is another notable benefit. These pumps can operate continuously for up to 24 hours, ensuring that patients receive a consistent and precise dosage of medication over a specified period. They also allow for the mixing and administering of multiple medications simultaneously, significantly reducing the need for frequent injections and improving patient comfort.

The demand for syringe infusion pumps is expected to grow due to their ability to deliver an accurate dosage over extended periods, which is increasingly essential in both acute and chronic care settings. This growth is further supported by the introduction of new and innovative products that have received regulatory approvals. For example, in August 2021, Baxter's Novum IQ syringe infusion pump received FDA 510(k) clearance. This device enhances the infusion process with advanced safety features, improved connectivity, configurable anesthesia care settings, and a user-friendly interface, emphasizing precision and reliability in medication delivery.

Given these developments, the syringe infusion pump segment is anticipated to experience notable growth, significantly contributing to the expansion of the overall infusion therapy device market from 2024 to 2030.

North America Is Expected To Dominate The Overall Infusion Therapy Devices Market:

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

According to 2023 data from the Centers for Disease Control and Prevention (CDC), approximately 53.2 million people, or one in five U.S. adults, had doctor-diagnosed arthritis between 2019 and 2021. Arthritis is more prevalent among women (20.9%) than men (16.3%), and the likelihood of developing the condition increases with age. Notably, the prevalence of arthritis is higher among those with no leisure-time physical activity (30.9%) compared to those who are somewhat active (27.0%) or meet physical activity recommendations (18.8%). For individuals with arthritis where oral medications are ineffective, infusion therapy serves as a vital alternative, offering direct and rapid delivery of medication into the bloodstream.

The market is also stimulated by the strategic activities of leading companies based in the region, such as Mindray, Baxter, and Becton, Dickinson and Company. These firms play a critical role in the sector's growth through continuous innovation and new product offerings. For instance, in February 2023, Mindray launched its BeneFusion i and u Series infusion systems, which are notable for their high precision and user-friendly design. Featuring an intuitive full touch screen and a flat design that highlights essential parameters, the BeneFusion series enhances visibility and usability for medical staff, allowing for safer and more precise operations.

The convergence of these factors, along with ongoing product launches and regulatory approvals, underscores the significant role North America will continue to play in driving the growth of the global Infusion Therapy Devices market from 2024 to 2030.

Infusion Therapy Devices Market Key Players:

Some of the key market players operating in the Infusion Therapy Devices Market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and Others.

Recent Developmental Activities In The Infusion Therapy Devices Market:

  • In August 2021, Baxter got the approval of U.S. Food Drug Administration (FDA) 510 (k) clearance for its Novum IQ syringe infusion pump.
  • In January 2022, ICU Medical Inc. finalized the acquisition of Smiths Medical from Smiths Group plc. This strategic move brings together a comprehensive portfolio encompassing syringe infusion devices, ambulatory infusion devices, vascular access solutions, and vital care products. By integrating the ambulatory infusion devices and vascular access offerings from Smiths Group plc with ICU Medical's Vital care products, the newly formed entity emerges as a prominent player in the infusion therapy sector, poised to exert a significant global presence.

Key Takeaways From The Infusion Therapy Devices Market Report Study

  • Market size analysis for current Infusion Therapy Devices market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Infusion Therapy Devices market.
  • Various opportunities are available for the other competitors in the Infusion Therapy Devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current Infusion Therapy Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Infusion Therapy Devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Infusion Therapy Device Market Report Study

  • Infusion Therapy Devices product providers
  • Research organizations and consulting companies
  • Infusion Therapy Devices organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in Infusion Therapy Devices
  • Various end-users who want to know more about the infusion therapy device market and the latest innovations and developments in the infusion therapy device market.

Frequently Asked Questions For The Infusion Therapy Devices Market

1. What are Infusion Therapy Devices?

An infusion pump is a medical device utilized to administer fluids, including nutrients and medications, into a patient's body with precise control over the dosage. Widely employed across various clinical environments such as hospitals, nursing homes, and home care settings, these devices play a crucial role in medical treatment.

2. What is the market for global Infusion Therapy Devices?

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030.

3. What are the drivers for the global infusion therapy devices market?

The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy device market throughout the forecast period spanning from 2024 to 2030.

4. Who are the key players operating in the global infusion therapy devices market?

Some of the key market players operating in the Infusion Therapy Devices market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and others.

5. Which region has the highest share in the infusion therapy devices market?

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

Table of Contents

1. Infusion Therapy Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Infusion Therapy Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Infusion Therapy Devices Market Key Factors Analysis

  • 5.1. Infusion Therapy Devices Market Drivers
    • 5.1.1. Growing prevalence of Diabetes and other Chronic diseases
    • 5.1.2. Growing geriatric population
  • 5.2. Infusion Therapy Devices Market Restraints and Challenges
    • 5.2.1. High Cost of Infusion Therapy Devices
    • 5.2.2. Risk of developing infections while using infusion therapy device
  • 5.3. Infusion Therapy Devices Market Opportunity
    • 5.3.1. Advancing smart technologies like- real-time monitoring, connectivity, and personalized treatment plans.

6. Infusion Therapy Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes s
  • 6.5. Competitive Rivalry

7. Infusion Therapy Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Syringe Infusion Pumps
    • 7.1.2. Large Volume Pumps (LVP)
    • 7.1.3. Elastomeric Pumps
    • 7.1.4. Others
  • 7.2. By Mobility
    • 7.2.1. Portable Infusion Pumps
    • 7.2.2. Stationary Infusion Pumps
  • 7.3. By Application
    • 7.3.1. Multiple Sclerosis
    • 7.3.2. Diabetes
    • 7.3.3. Rheumatoid Arthritis
    • 7.3.4. Cancer
    • 7.3.5. Others
  • 7.4. End-User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Homecare
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.5. Spain Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.3. India Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Infusion Therapy Devices Market Size in USD million (2021-2030)

8. Infusion Therapy Devices Market Company and Product Profiles

  • 8.1. Fresenius Kabi AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Ossila
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Ace-medical
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ICU Medical
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Chmyx inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Mindray
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Baxter
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Becton, Dickinson and Company
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Micrel Medical Devices SA
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. AKAS Infusions
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Narang Medical Limited
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Monidor Oy.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Smiths Group plc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. B. Braun SE
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Trivitron Healthcare
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Eitan Medical
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제